• Return to Headlines

Highest Level of Efficiency in the Biotechnology Industry Detected in Shares of PDL BioPharma (PDLI, TRMS, AMLN, GILD, NPSP)

Written on Wed, 06/23/2010 - 4:07am
By Chip Brian

Below are the top five most-efficient companies in the Biotechnology industry as ranked by Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.
PDL BioPharma (NASDAQ:PDLI) ranks first with an RPE of $45.37M; Trimeris (NASDAQ:TRMS) ranks second with an RPE of $3.46M; and Amylin Pharmaceuticals (NASDAQ:AMLN) ranks third with an RPE of $2.11M.
Gilead Sciences (NASDAQ:GILD) follows with an RPE of $1.96M and NPS Pharmaceuticals (NASDAQ:NPSP) rounds out the top five with an RPE of $1.66M.
SmarTrend is bearish on shares of GILD and our subscribers were alerted to Sell on March 26, 2010 at $45.67. The stock has fallen 21.4% since the alert was issued.

Keywords: keywords: nasdaq:pdli pdl biopharma revenue per employee

Ticker(s): PDLI TRMS AMLN GILD NPSP

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.